Details of the Drug
General Information of Drug (ID: DM5HV4W)
Drug Name |
Rolicyclidine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
ROLICYCLIDINE; PCPy; 1-(1-Phenylcyclohexyl)pyrrolidine; Rolicyclidinum; Roliciclidina; 2201-39-0; Rolicyclidinum [INN-Latin]; Roliciclidina [INN-Spanish]; UNII-183O9O9JE3; DEA No. 7458; CHEBI:60805; Pyrrolidine analog of phencyclidine; 183O9O9JE3; Pyrrolidine, 1-(1-phenylcyclohexyl)-; NCGC00160464-01; Rolicyclidine [INN]; PCP pyrrolidine analog; DSSTox_RID_81398; DSSTox_CID_26167; DSSTox_GSID_46167; SCHEMBL517928; AC1L1X48; DTXSID8046167; CHEMBL1719398; HSDB 7636; FYOWWXMGDATDQY-UHFFFAOYSA-N; 1-(1-phenylcyclohexyl)-pyrrolidine
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 229.36 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||